As of October 2026 Retension Pharmaceuticals has a market cap of A$0.20 Billion. This makes Retension Pharmaceuticals the world's 9434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.